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RESEARCH ARTICLE Open Access
Course of serum amyloid A (SAA) plasma
concentrations in horses undergoing
surgery for injuries penetrating synovial
structures, an observational clinical study
Eva Haltmayer1* , Ilse Schwendenwein2 and Theresia F. Licka1,3
Abstract
Background: Injuries penetrating synovial structures are common in equine practice and often result in septic
synovitis. Significantly increased plasma levels of serum amyloid A (SAA) have been found in various infectious
conditions in horses including wounds and septic arthritis. Plasma SAA levels were found to decrease rapidly once
the infectious stimulus was eliminated. The purpose of the current study was to investigate the usefulness of serial
measurements of plasma SAA as a monitoring tool for the response to treatment of horses presented with injuries
penetrating synovial structures. In the current study plasma SAA concentrations were measured every 48 hours (h)
during the course of treatment.
Results: A total of 19 horses with a wound penetrating a synovial structure were included in the current study.
Horses in Group 1 (n = 12) (injuries older than 24 h) only needed one surgical intervention. Patients in this group
had significantly lower median plasma SAA levels (P = 0.001) between 48 h (median 776 mg/L) and 96 h (median
202 mg/L) after surgery. A significant decrease (P = 0.004) in plasma SAA levels was also observed between 96 h
after surgery (median 270 mg/L) and 6 days (d) after surgery (median 3 mg/L). Four horses (Group 2) required more
than one surgical intervention. In contrast to Group 1 patients in Group 2 had either very high initial plasma
concentrations (3378 mg/L), an increase or persistently high concentrations of plasma SAA after the first surgery
(median 2525 mg/L). A small group of patients (n = 3) (Group 3) were admitted less than 24 h after sustaining a
wound. In this group low SAA values at admission (median 23 mg/L) and peak concentrations at 48 h after surgery
(median 1016 mg/L) were observed followed by a decrease in plasma SAA concentration over time.
Conclusions: A decrease in plasma SAA concentrations between two consecutive time points could be associated
with positive response to treatment in the current study. Therefore, serial measurements of plasma SAA could
potentially be used as an additional inexpensive, quick and easy tool for monitoring the treatment response in
otherwise healthy horses presented with injuries penetrating synovial structures. However further studies will be
necessary to ascertain its clinical utility.
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Background
Injuries penetrating synovial structures are common in
equine practice [1, 2, 3]. These injuries cause contamination
of the affected synovial structure and can subsequently lead
to septic synovitis. Septic synovitis is a serious and poten-
tially lethal condition in horses that requires immediate
diagnosis and subsequent treatment [4–6]. Arthroscopic
lavage is the recommended treatment of choice [2, 7–9].
However, more invasive approaches have been described in
severely affected cases [10–12]. With adequate treatment,
survival rates in adult horses range from 84% [6] to 90% [2]
with 54% [6] to 81% [2] of horses returning to previous
levels of performance [2, 4–6], except horses where solar
foot penetration caused septic synovitis. In one larger scale
study by Findley et al. [3] survival to discharge was only 56
and 36% returned to their previous athletic function. Intro-
duction of pathogens into a synovial cavity causes a strong
inflammatory response resulting in local swelling, heat and
pain and eventually leading to enzymatic breakdown of hya-
luronic acid and cartilage [7]. The inflammatory response is
mainly driven by the release of cytokines from macrophages
and monocytes at the site of injury. These pro-
inflammatory mediators especially interleukin-1 (IL-1),
tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-
6) stimulate the hepatic acute phase protein synthesis [13]
once released into circulation. In horses, serum amyloid A
(SAA) was shown to be a reliable marker of various septic
and non-septic inflammatory conditions [13–18]. SAA is a
major acute phase protein in equids and characterized by a
rapid and remarkable increase (up to several 1000-fold)
from low to undetectable baseline values in plasma concen-
tration and a rapid decrease, once inflammatory or infec-
tious stimuli are eliminated [13, 18]. SAA reaches peak
concentrations in plasma about 48 h after the onset of in-
flammation [18]. Jacobsen et al. [17] were the first to docu-
ment that septic arthritis elicits a prominent acute phase
response with significantly higher SAA concentrations in
serum compared to healthy horses and horses with non-
septic arthritis. Diagnosis and monitoring of successful
treatment in patients with injuries penetrating synovial
structures commonly relies on repeated synoviocentesis of
the affected structure and subsequent synovial fluid analysis
[19] as well as clinical signs such as lameness, heat and
swelling. Synovial fluid analysis can be inconclusive under
certain circumstances especially after repeated synoviocent-
eses [17, 20, 21] or drug application [20, 21]. Moreover, re-
peated synoviocentesis and subsequent collection of
synovial samples can be difficult, especially under field con-
ditions. Fibrin formation, synovial hypertrophy, and loss of
synovial fluid via drainage through an open wound can also
interfere with successful collection of a synovial fluid sam-
ple. To our knowledge, there are only limited reports about
serial SAA measurements [17] over the course of treatment
for assessment of treatment success.
The aim of the present study was to evaluate the
course of plasma SAA over time in patients undergoing
treatment for injuries penetrating synovial structures
and to evaluate plasma SAA as a potential marker for
treatment response. Hypothesis tested is that plasma
SAA concentrations decrease significantly in response to
successful treatment.
Methods
Animals
Horses over 1 year of age admitted to the Equine Hos-
pital, University of Veterinary Medicine Vienna, Austria
for investigation and treatment of injuries penetrating
synovial structures between May 2012 and January 2013
were included in the study. Inclusion criteria were injur-
ies (lacerations, open fractures, puncture wounds and
street nail injury) penetrating synovial structures and re-
quiring surgical intervention. Pregnant mares and horses
younger than 1 year, as well as horses with clinically
relevant medical conditions prior to the development of
the presenting complaint such as horses with additional,
not wound associated infections or inflammatory condi-
tions were excluded from the study.
Remnants of plasma samples obtained for routine
blood work were used for SAA measurements, or blood
was withdrawn from a previously placed intravenous
(IV) catheter. No invasive procedure was performed for
study purposes only. Owner’s written consent was ob-
tained at admission.
For description of results and statistical analysis horses
were divided into three Groups. Group 1 (n = 12) consisted
of horses with injuries older than 24 h, Group 2 (n = 4)
were horses that required more than one surgical interven-
tion/one lavage and Group 3 (n = 3) consisted of horses
with fresh (< 24 h) injuries. Decision for further lavages was
taken by the clinician in charge of the case based on clinical
findings and results of synovial fluid analysis.
Initial assessment
A thorough clinical examination and routine blood work
(complete blood count, creatinine, total protein, glutam-
ate dehydrogenase, gamma-glutamyl transferase, creatin-
ine kinase, potassium and fibrinogen) was performed on
each patient. Samples for routine blood work were ob-
tained by venipuncture of the jugular vein using a vacu-
tainer system (Vacuette, Greiner Bio-One GmbH,
Frickenhausen, Germany) or from a venous catheter. On
admission, horses underwent a limited orthopaedic
examination, as was decided relevant by the clinician in
charge of the case. No evaluation at trot, no flexion tests
and no diagnostic anaesthesia was performed, as the
horses were lame at the walk and/or had obvious
wounds and swellings. Additionally, radiographic and/or
ultrasonographic examinations were performed.
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Centesis of at least 1 synovial structure adjacent to the
injury was carried out, and when possible synovial fluid
was collected. If no synovial fluid sample could be ob-
tained, the involved synovial structure was distended
with sterile saline solution to identify communication
with a wound. In cases where no synovial fluid sample
could be aspirated sterile saline solution was injected
and immediately re-aspirated to obtain a synovial lavage
sample. Synovial samples were analysed at the Clinical
Pathology Unit, University of Veterinary Medicine
Vienna, Austria by one of the authors (IS). A smear and
a cytospin were prepared from native and lavage samples
and stained with a Romanowsky-type stain (Haemafix™
Biomed Labordiagnostik GmbH, Oberschleißheim,
Germany) for verification of automated cell counts, cell
differentiation and evaluation of mucin precipitate. The
concentration of nucleated cells (TNCC) was deter-
mined in undiluted samples with a laser based
hematology system (Advia 2120™, Siemens Diagnostics,
Erlangen, Germany). To samples with high viscosity,
which were inappropriate for automated counting a
grain of hyaluronidase powder was added, so that they
could be analysed. In diluted samples only the ratio of
neutrophils and monocytes was analysed. Total protein
concentration was evaluated by refractometry from un-
diluted samples. An injury penetrating synovial struc-
tures was confirmed when communication of the injury
with a synovial cavity was found (positive pressure test)
and/or synovial fluid analysis results showed TNCC
>20 × 103/μL and/or neutrophils >80% and total protein
>4 g/dL [19, 22]. Pathological findings on physical exam-
ination (lameness, swelling, heat, fever) were also taken
into account.
Preoperative treatment and surgery
All treatment decisions were carried out by the clinician
in charge of the case. Preoperatively, an intravenous
catheter was placed in a jugular vein, and all patients re-
ceived systemic broad spectrum antimicrobials: penicil-
lin (30.000 IU/kg, IV, every 6 h) and gentamicin (6.6 mg/
kg, IV, once daily). When indicated by results of anti-
microbial susceptibility tests, marbofloxacin (2 mg/kg,
IV, once daily) or cefquinome (2.2 mg/kg, IV, once daily)
were used. All patients received non-steroidal anti-
inflammatory drugs (NSAIDs): flunixin meglumine
(1.1 mg/kg, IV, twice daily) or phenylbutazone (2 mg/kg,
PO, twice daily). Patients were treated surgically by
standard wound debridement and lavage of the affected
synovial structure under general anaesthesia or standing
under sedation and regional anaesthesia. Lavage was per-
formed either through 16G and 18G needles or arthros-
copically. All affected synovial structures were closed
after lavaging. Details about patients and treatment pro-
cedures are displayed in Table 1.
Postoperative management
After surgery horses were kept on systemic antimicrobials
and NSAIDs. Antimicrobials, a combination of 250 IU
bacitracin and 5000 IU neomycin or 500 mg amikacin
were instilled into the synovial structure after lavage and
after each synovial centesis. In some cases distal regional
limb perfusions (DRLP) with 500 mg amikacin were per-
formed in addition. During hospitalization, horses were
examined clinically at least once a day (lameness assess-
ment at the walk and physical examination). Horses re-
ceived bandage changes every 2–3 days or as needed.
SAA samples and assay
Blood samples for plasma SAA measurements were
taken at admission (before initial surgical treatment)
and subsequently every 48 h until infection was con-
sidered to be resolved (improved clinical presentation,
synovial fluid analysis within normal limits)-this was
taken as a favourable response to treatment. Samples
were collected from a previously placed intravenous
catheter or where routine blood work was taken at
time point representing the 48 h interval remnants of
plasma samples from this routine blood work were
used. Venous blood samples were collected into blood
tubes containing heparin and centrifuged. The super-
natant was either analysed immediately, if the clin-
ician in charge of the case decided to include SAA
analysis in the routine blood work, or frozen at −20 °
C and stored for a maximum of 60 days until ana-
lysis. Analyses were performed at the Clinical Path-
ology Unit, University of Veterinary Medicine Vienna,
Austria, using a commercially available immunoturbi-
dimetric assay (LZ test SAA, Eiken Chemical Co,
Tokyo, Japan) validated for use in horses in a prior
study [23] and re-evaluated and adapted on a fully se-
lective autoanalyser for clinical chemistry (Cobas
™501c, Roche Diagnostics, Vienna, Austria) by the De-
partment for Clinical Pathology [24]. Cut-off value of
<10 mg/L was established for the local population of
healthy horses prior to the present study [24].
Statistical methods
Patients of Group 2 and Group 3 were excluded from
statistical analysis due to the low number of patients.
Statistical analyses were performed using MedCalc
11.3.1.0 package (MedCalc Software bvba, Ostend,
Belgium). All probabilities were two-tailed and P values
<0.05 were regarded significant. To test for normality a
Kolmogorov-Smirnov test was performed. Univariate
comparisons of two consecutive plasma SAA measure-
ments were performed with the non-parametric Wil-
coxon test for paired samples (respective P-values were
not adjusted for multiple comparisons).
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Table 1 Detailed patient information reporting age (in years), breed, sex, diagnosis, treatment, complications and synovial fluid
parameters
Group Patient Signalement Diagnosis Surgical treatment Repeated AL/
standing
lavage
Complications Duration
of injury
Synovial
parameters
at
admissiona
Duration of
treatment
1 2 Trotter, 6y, S Pastern
laceration right
hind, septic
digital flexor
tendon sheath
Wound debridement;
standing needle
lavage digital flexor
tendon sheath
None >24 h Positive
pressure test;
>80%
neutrophils;
3200 TNC/
μL;
TP 4 g/dL
4 days
treatment was
continued by
referring
veterinarian
1 5 Gidran, 13y, G Laceration left
tarsus, septic
tarsal sheath
Wound debridement;
AL tarsal sheath; GA
None 2 days >85%
neutrophils;
and positive
pressure
test
9 days
1 6 Cob, 13y, M Street nail injury
right front,
septic distal
interphalangeal
joint
AL distal
interphalangeal joint;
GA
Euthanasia
d 30 of
hospitalization
after
developing
septic
navicular
bursitis right
front
2 days >95%
neutrophils;
200 TNC
/400xHPF;
TP 7,2 g/dL
15 days for
septic
interphalangeal
joint
1 8 Nonius, 9y, G Street nail injury
left hind, septic
navicular bursa
BL navicluar bursa:;
GA
none 5 days >95%
neutrophils;
positive
pressure
test
14 days
1 11 WB, 18y, G Puncture
wound left hind
fetlock, cellulitis
Debridement and
standing needle
lavage
metatarsophalangeal
joint
Euthanasia
after discharge
due to
laminitis right
hind
>2 days 80%
neutrophils;
3200 TNC/
μL;
TP 3 g/dL
16 days
1 12 Cob, 16y, M Laceration left
tarsus septic
tarsometatarsal
joint
needle lavage
tarsometatarsal joint:
GA
Euthanasia on
d 27 of
hospitalisation
due to
osteomyelitis
left Mt. IV
4 days >95%
neutrophils;
positive
pressure
test
19 days for
septic
tarsometatarsal
joint
1 13 Pony, 20y, G Laceration,
bone sequester
left humerus,
septic bicipital
bursa
Needle lavage,
sequestrectomy,
standing
None >24 h Positive
pressure
test
28 days
1 14 Icelandic
horse, 15y, M
Laceration left
elbow; septic
elbow joint,
open
intraarticular
olecranon
fracture
Type II
AL elbow joint,
fracture repair; GA
None >24 h Positive
pressure
test
26 days
1 15 WB, 24y, G Laceration SDFT
and DDFT right
hind, septic
digital flexor
tendon sheath
TVL digital flexor
tendon sheath; GA
Scar tissue
formation
SDFT
2 days Positive
pressure test;
>75%
neutrophils;
21,910 TNC/
μL; TP 4 g/dL
10 days
1 16 Icelandic
horse, 2y, M
Laceration right
carpus septic
carpal joints
AL carpal joints; GA None >36 h Positive
pressure test;
>80%
12 days
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Table 1 Detailed patient information reporting age (in years), breed, sex, diagnosis, treatment, complications and synovial fluid
parameters (Continued)
neutrophils;
26,670 TNC/
μL; TP 3,4 g/
dL
1 18 Arab, 17y, M Laceration left
tarsus, septic
tarsocrural
joint/open
comminuted
calcaneus
fracture
standing needle
lavage tarsocrural
joint;
Euthanasia on
d 7 of
hospitalisation
due to pleural
effusion, heart
failure
>36 h Positive
pressure
test; >96%
neutrophils;
10,270 TNC/
μL; TP 5 g/
dL
6 days
1 20 WB, 12y, G Laceration right
front fetlock
septic digital
flexor tendon
sheath
TVL digital flexor
tendon sheath; GA
Adhesions
formation
SDFT and
digital tendon
sheath;
7 days Positive
pressure
test; >88%
neutrophils;
310 TNC/
400× HPF;
TP 3,5 g/dL
18 days
2 4 WB, 8y, G Laceration right
stifle; septic
femoropatellar
joint
Wound debridement;
AL femoropatellar
joint: GA
Yes; AL; GA;
48 h after first
surgery
None 36 h Positive
pressure
test; >80%
neutrophils;
8700 TNC/
μL;
TP 4,6 g/dL
9 days
2 7 QH, 4y, G Laceration right
carpus septic
middle carpal
joint;
osteomyelitis
carpal accessory
bone
AL middle carpal
joint: GA
8 days after
first surgery;
curettage of
carpal
accessory
bone, GA; no
AL indicated
Osteomyelitis
accessory
carpal bone
>2 days positive
pressure
test; >80%
neutrophils;
120 TNC/
400× HPF;
TP 6,4 g/dL
28 days
2 17 Polo Pony,
16y, G
Puncture
wound left
tarsus; septic
tarsal sheath
AL tarsal sheath; GA Yes; AL; GA
96 h after
initial surgery
4 days >95%
neutrophils;
>100 TNC/
400× HPF;
TP 7,2 g/dL
23 days
2 19 Trotter, 8y, M Laceration right
carpus septic
carpal joints
AL carpal joints; GA Yes; 3 ALs GA
48 h, 96 h and
6 days after
initial surgery
5 days >90%
neutrophils;
36,600 TNC/
μL; TP 6 g/
dL
36 days
3 1 WB, 3y, M Laceration left
tarsus,
contaminated
tarsocrural joint
wound debridement;
AL tarsocrural joint:
GA
None 5 h >90%
neutrophils;
35,880 TNC/
μL; TP 5 g/
dL
12 days
3 3 Criollo, 20y, M Street nail injury
right hind;
contaminated
navicular bursa
BL navicular bursa;
GA
None 6 h Positive
pressure
test
20 days
3 9 WB, 9y, M Pastern
laceration left
hind,
contaminated
digital flexor
tendon sheath
TVL digital flexor
tendon sheath; GA
None 4 h Positive
pressure
test; >95%
neutrophils;
14,220 TNC/
μL; TP 2,4 g/
dL
10 days
M mare, S stallion, G gelding, WB warmblood, QH quarter horse, Mt. IV fourth metatarsal bone, DDFT deep digital flexor tendon, SDFT superficial digital flexor
tendon, GA general anaesthesia, DRLP distal regional limb perfusion, AL arthroscopic lavage, TVL tendovaginoscopic lavage, BL bursoscopic lavage, HPF high power
field, TP total protein
anot all parameters were available for each patient, dependent on the amount of synovial fluid/if synovial fluid was obtained
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Results
Study population and samples
Nineteen horses admitted to the University Clinic for
Horses, University of Veterinary Medicine Vienna,
Austria, between May 2012 and January 2013 matched
the inclusion criteria. Horses were of mixed breed and
age. Females and males were evenly distributed.
Patient details including clinical data and surgical pro-
cedures are displayed in Table 1.
In 15 patients an arthroscopy/bursoscopy/tendovagi-
noscopy and lavage of the affected synovial structure
was performed under general anaesthesia.
In 5 patients wound revision and lavage of the affected
synovial structure was performed standing under sed-
ation and regional anaesthesia through 16G or 18G nee-
dles. Decision on needle lavage was based on the
presence of a calcaneal fracture in case 18, on the risk of
a humeral fracture during recovery in case 13, on the
anatomy of the joint involved in case 12 and on financial
considerations in the remaining cases.
Post operatively horses were kept on systemic broad-
spectrum antimicrobials and NSAIDs for a median of
10.5 days (range 7–25 days). Four patients received a
median of 3 (range 2–4) DRLPs with antimicrobials. In 9
patients repeated synoviocentesis was performed to
monitor treatment success and intrasynovial antimicro-
bials were administered after each procedure.
Plasma SAA concentrations
Statistical analysis was not performed in Group 2 and 3
due to the limited number of patients.
Median plasma SAA values of all Groups are displayed
in Table 2.
Patients in Group 1 showed a significant decrease in
plasma SAA concentrations over the course of treat-
ment: Patients in that group had two different rise and
fall pattern. Four individuals showed the peak concentra-
tion at time of admission and the remaining patients
had peak concentrations at 48 h after surgery. Time of
injury to admission was not connected to one of the rise
and fall pattern in Group 1 (Fig. 1a).
The median percentage decrease of plasma SAA in
this group was 70% (range 18–100%) between 48 and
96 h and 99% (range 17–100%) between 96 h and 6 days
after initial surgical intervention. Results of pairwise
comparison of two time points of measurement are dis-
played in Fig. 1b.
Patients in Group 2 showed variable patterns of
plasma SAA concentration over time. Two horses (4, 19)
showed persistently high or even increased levels of SAA
after the first surgery, patient 17 showed a very high in-
crease between the first and the second surgery and pa-
tient 7 showed very high initial SAA values and only a
minor decrease before the second surgery (Fig. 2). This
represents a median increase in plasma SAA concentra-
tions of 24% (range − 40 − +100%) between 48 and 96 h
and a median decrease of only 60% (range 15–85%) be-
tween 96 h and 6 days after the first surgery. Especially
in Patient 19 the increase before surgery can be well ob-
served (Fig. 2).
Patients in Group 3 showed typical rise and fall pat-
tern with a peak at 48 h after initial surgical treatment.
In that Group injuries happened <24 h before admission
(Fig. 3). The median decrease of plasma SAA levels was
60% (range 9–84%) between 48 and 9 h post initial treat-
ment and 98% (range 61–100%) between 96 h and 6 days
after surgery.
Discussion
In the current study we monitored the course of plasma
SAA concentrations in response to treatment in 19
otherwise healthy horses with injuries penetrating syn-
ovial structures. Plasma SAA concentrations in cases
with injuries penetrating synovial structures decreased
rapidly in response to treatment and returned to levels
below the reference value (10 mg/L) during the course
of successful treatment (Figs.1a, 3). Therefore SAA ana-
lysis offers a timely and useful tool for monitoring the
effect of treatment of injuries penetrating synovial struc-
tures. Jacobsen et al. [17] mentioned in their study that
plasma SAA concentration in one horse with septic arth-
ritis decreased during the course of treatment. This
could also be observed in the present study in horses
treated for injuries penetrating synovial structures. To
the authors’ knowledge, this is the first study investigat-
ing the utility of serial plasma SAA measurements for
Table 2 Median (range) of plasma SAA values (mg/L) of horses over their course of treatment for injuries penetrating synovial
structures. Group 1: horses with injuries older than 24 h requiring only a single surgical intervention, Group 2: horses that required
more than one surgical intervention, Group 3: horses with wounds of less than 24 h
pre OP 48 h 96 h 6 days*
Group 1 (n = 12) 454 (275–6378) a 776 (422–2100) a 201 (19–864) b 5 (0–17) c
Group 2 (n = 4) 940 (16–3378) 2525 (495–4000) 2593 (811–3370) 1000 (122–2618)
Group 3 (n = 3) 23 (7–77) 1016 (273–1666) 297 (159–500) 5 (0–17)
pre OP preoperative
Different letters indicate significant difference (P < 0.05) between time-points of SAA measurements during treatment
*At time point 6 days data was available from 9 horses in Group 1, 4 horses in Group 2 and 2 horses in Group 3.
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monitoring treatment response in patients with injuries
penetrating synovial structures in a clinical set up. Data
indicates that the course of plasma SAA concentration
reflects the response to treatment well. Patients of
Group 1 and 3 with a highly favourable response to ini-
tial surgical treatment showed a continuous decrease of
SAA concentrations between 48 and 96 h after surgery
as well 6 days after surgery. In contrast in cases with on-
going infection (Group 2) different patterns of SAA
could be observed. Two horses (4, 19) showed persist-
ently high or even increased levels of SAA after the first
surgery, one horse (17) showed a very high increase be-
tween the first and the second surgery and the other
horse (7) showed very high initial SAA values and only a
minor decrease before the second surgery. However this
has to be interpreted with care due to the low number
of patients and no conclusion can be drawn from the
data at this point.
Persistently high concentrations of SAA have been pre-
viously reported in horses with complications after elect-
ive and emergency surgery [14, 25, 26]. In the present
study this was considered to be an indication for lack of
treatment response. However, further surgical treatment
was instigated only with corresponding clinical signs and
synovial fluid analysis and was not based on SAA values.
This does not preclude that animals could have potentially
improved without additional intervention. However, such
an experimental set up cannot be used in client owned
Fig. 1 a Course of plasma SAA of all patients in Group 2. Peak values could be observed between pre OP (n = 4) and 48 h after surgery (n = 7).
Notice the continuous decrease of plasma SAA concentrations after surgery. b Box and whisker plots of course of plasma SAA concentration
during treatment of patients of Group 1 Explanations: In box-and-whisker plots, central box represents values from lower to upper quartile, middle
line represents the median; whiskers extend from minimum to maximum value, excluding outside and far out values which are displayed as
separate points
Fig. 2 Course of plasma SAA in horses of Group 2 Timepoints of surgery are marked (+). In patients 4 and 19 an increase of plasma SAA was
observed before the following surgical treatment. Patient 7 showed very high initial SAA values with only a minor decrease before the second
surgical intervention. Patient 17 showed an unusual high increase after the first surgery
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horses. The time interval of 48 h for SAA sample collec-
tion in the present study was chosen because SAA shows
peak concentration 48 h after onset of infection [13, 18].
Concentrations of SAA correspond to the severity of tis-
sue damage as well as to the volume of damaged tissue
[18] and drop rapidly as soon as synthesis stops [18]. Due
to these unique features of SAA sequential measurements
of plasma SAA concentrations were suggested as a useful
aid in patient management, planning of treatment strat-
egies and in decision-making whether to perform surgery
or not [13, 18].
Duration of the disease process prior to admission as
well as the stage of the disease process at admission have
to be carefully considered when interpreting SAA concen-
trations in a patient [17, 18]. In the current study patients
in Group 3 had normal or very low SAA concentrations
(range from 6.7 mg/L to 23.1 mg/L) at the time of admis-
sion, despite a positive pressure test and/or neutrophil
counts >90% in synovial fluid. In these patients the re-
ported duration between detection of injury by the owner
and hospital admission was <24 h thus below the reported
lag time for SAA increase. Jacobsen et al. [17] also de-
scribed one case where the authors assumed that the time
from injury to sample collection was too short for the
local inflammatory response to induce hepatic SAA syn-
thesis. In this particular case the delay between injury and
sample collection was only 2 h. The three patients in
Group 3 support this suggestion [17]. Therefore care has
to be taken when interpreting single SAA values, espe-
cially in early stages of disease and results of the current
study strongly suggest that SAA values obtained at a single
time point should not be used for diagnostic purposes.
Also low-grade infections [14] and well sequestrated
infections [14] were previously reported to cause a re-
tarded response in plasma SAA in relation to clinical
signs. This can be explained by a local inflammatory re-
sponse that is not “strong” enough to trigger SAA synthe-
sis in the liver and incite a systemic inflammatory
response. In contrast Belgrave et al. [14] reported that
SAA values were increased 24 h prior to onset of clinical
signs in horses with colic and metritis [13] and therefore
SAA could potentially aid in early detection of inflamma-
tion. However due to the limited number of patients in
Group 3 no conclusions can be drawn at this point.
In the present study most patients showed peak concen-
tration of plasma SAA 48 h after surgery. In all cases sur-
gery was performed on the day of hospital admission.
Therefore, peak values might have been influenced by the
degree of infection of the injury site and/or the synovial
structure, as well as by surgical trauma [25–27], general an-
aesthesia [28, 29] or antimicrobial treatment [30]. Jacobsen
et al. [27] reported slightly increased plasma SAA values up
to 5 days after arthroscopy (up to 100 mg/L), however these
levels remain much lower than in the cases of the present
study [26]. Sanchez-Teran et al. [31, 32] recently suggested
in their study that in healthy adult horses neither arthro-
scopic lavage nor through-and-through joint lavage with
needles influenced plasma SAA concentrations 48–120 h
after surgery. Moreover, Pollock et al. [26] described that
healthy horses undergoing an elective surgery responded
similar to surgical trauma than horses with elevated plasma
SAA concentrations undergoing emergency surgery. In four
patients in Group 1 a decrease in plasma SAA could be ob-
served between admission and 48 h after surgery (Fig. 1a).
These results do not support the suggestion that surgical
trauma alone led to the typical rise and fall pattern post-
Fig. 3 Illustration of the typical rise and fall pattern of plasma SAA concentrations of patients with injuries <24 h. Peak concentrations are observed
48 h after surgery. Notice the relative low pre OP plasma SAA values
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surgery, however due to the low number of cases no con-
clusion can be drawn.
Currently little and controversial information is avail-
able regarding the effects of general anaesthesia on
plasma SAA concentrations. One study reported no in-
crease in plasma SAA concentrations after general an-
aesthesia [28], another study reported values of up to
520.7 mg/l in horses 24 h after general anaesthesia of a
maximum of 2 h duration without surgery [29]. How-
ever, the latter study also reported high inter-individual
differences so that high and low responders among
horses could be discussed.
All patients enrolled in the current study received
NSAIDs during the course of treatment. The effect of
non-steroidal anti-inflammatory drugs on the acute phase
response has been investigated studies in various species
(dogs, ruminants, humans) other than horses [33–35].
These studies showed that administration of non-steroidal
anti-inflammatory drugs did not affect the acute phase re-
sponse in comparison to a non-treated control group. On
the other hand some studies exist that state the opposite
[36, 37]. Based on these contradictory information it re-
mains unclear whether the course of SAA was affected by
administration of NSAIDs in horses in the current study.
This leaves room for further studies investigating the ef-
fect of NSAIDs on SAA response in horses with injuries
penetrating synovial structures. Increased plasma SAA
concentrations were observed in pregnant mares starting
1 week before parturition until 1 month post partum [16].
Therefore pregnant mares were excluded from the present
study. Horses younger than 1 year were also excluded
from the present study because differentiation between
traumatic septic arthritis and septic arthritis/physitis in
foals was deemed to be potentially imprecise.
Nunokawa et al. [38] described in their study that various
inflammatory and infectious diseases lead to increased
plasma SAA concentrations in horses. Therefore in pa-
tients with multiple inflammatory processes plasma SAA
concentrations are only of limited use for monitoring re-
sponse to treatment for injuries penetrating synovial struc-
tures. In horses with postoperative complications unrelated
to the site of injury that reportedly lead to an increase in
plasma SAA concentration such as gastrointestinal path-
ologies [39, 40] (eg. colitis) interpretation of SAA concen-
trations regarding the state of infection of the primary
injury by a single measurement might be challenging or
even impossible.
One limitation of the present study is that patients
presented with a variety of wounds and different types of
tissues involved. This, however, reflects a typical hospital
population and therefore allows testing the hypothesis in
a routine clinical setting.
These wounds led to various amounts of tissue dam-
age and infection of tissue surrounding the synovial
structure. Therefore it stands to reason that the pattern
of SAA during the course of treatment was likewise in-
fluenced by resolution of infection from the wound and/
or synovial structure.
In the present study two patients had fractures in
addition to the injuries penetrating synovial structures.
Plasma SAA concentrations therefore may have been in-
fluenced by the surgical trauma due to fracture repair in
patient 14 and trauma to the bone itself in both patients.
In patient 14 serial SAA measurements showed a de-
crease over the course of treatment which was consid-
ered a reflection of favourable response to treatment.
Patient 18 was euthanized due to heart failure. However
synovial analysis prior to euthanasia revealed no synovial
sepsis. In Patient 12 osteomyeltis of the fourth metatar-
sal bone was diagnosed after synovial sepsis of the tarso-
metatarsal joint was considered to be improved (clinical
improvement, low SAA). Consent for further treatment
was not given by the owner and the patient was eutha-
nised. In this case plasma SAA was within normal limits
despite the presence of osteomyelitis. The reason for the
lack of increased plasma SAA could not be determined
in this case. Another limitation of the present study is,
that due to the clinical design, the number of plasma
samples obtained per horse could not be standardised
more stringently. Number of samples obtained depended
on the time required for resolution of infection.
Conclusions
In summary the results of the present study suggest that
sequential measurement of SAA exhibiting continuously
declining concentrations seems to indicate a favourable
response to treatment. Serial plasma SAA concentrations
potentially offer a relatively inexpensive, non-invasive
and rapid method to monitor response to treatment in
injuries penetrating synovial structures. However due to
the small number of patients and the variation in the
data of the current study further investigations will be
necessary to ascertain the clinical value of plasma SAA
as a complementary monitoring tool in horses with in-
juries penetrating synovial structures.
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